DEF 14A

Company

SELLAS Life Sciences Group, Inc.

Filed

May 24, 2019

Period of Report

July 12, 2019

Accession Number

0001144204-19-028175

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →